skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Clinical efficacy and safety of novel antibiotics for complicated urinary tract infection: A systematic review and meta-analysis of randomized controlled trials
Clinical efficacy and safety of novel antibiotics for complicated urinary tract infection: A systematic review and meta-analysis of randomized controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical efficacy and safety of novel antibiotics for complicated urinary tract infection: A systematic review and meta-analysis of randomized controlled trials

Hung, Kuo-Chuan ; Tsai, Wen-Wen ; Hsu, Chin-Wei ; Lai, Chih-Cheng ; Tang, Hung-Jen ; Chen, I-Wen

International journal of antimicrobial agents, 2023-07, Vol.62 (1), p.106830-106830, Article 106830 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
12
Cost-Utility Analysis Comparing Meropenem with Imipenem Plus Cilastatin in the Treatment of Severe Infections in Intensive Care
Cost-Utility Analysis Comparing Meropenem with Imipenem Plus Cilastatin in the Treatment of Severe Infections in Intensive Care
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost-Utility Analysis Comparing Meropenem with Imipenem Plus Cilastatin in the Treatment of Severe Infections in Intensive Care

Edwards, Steven J. ; Campbell, Helen E. ; Plumb, Jonathan M.

The European journal of health economics, 2006-03, Vol.7 (1), p.72-78 [Periódico revisado por pares]

Germany: Springer

Texto completo disponível

Citações Citado por
13
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination

Mansour, Hanine ; Ouweini, Ahmad E L ; Chahine, Elias B ; Karaoui, Lamis R

American journal of health-system pharmacy, 2021-03, Vol.78 (8), p.674-683 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
14
Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections
Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections

Walters, D J ; Solomkin, J S ; Paladino, J A

PharmacoEconomics, 1999-11, Vol.16 (5 Pt 2), p.551-561 [Periódico revisado por pares]

New Zealand: Springer Healthcare | Adis

Texto completo disponível

Citações Citado por
15
University of Clermont-Auvergne Reports Findings in Pseudomonas aeruginosa (Determination of Antimicrobial Resistance and the Impact of Imipenem Plus Cilastatin Synergy With Tetracycline In ipseudomonas Aeruginosa/i Isolates From Sepsis)
University of Clermont-Auvergne Reports Findings in Pseudomonas aeruginosa (Determination of Antimicrobial Resistance and the Impact of Imipenem Plus Cilastatin Synergy With Tetracycline In ipseudomonas Aeruginosa/i Isolates From Sepsis)
Material Type:
Artigo 		Adicionar ao Meu Espaço

University of Clermont-Auvergne Reports Findings in Pseudomonas aeruginosa (Determination of Antimicrobial Resistance and the Impact of Imipenem Plus Cilastatin Synergy With Tetracycline In ipseudomonas Aeruginosa/i Isolates From Sepsis)

Obesity, fitness, & wellness week, 2024-01, p.5184

NewsRX LLC

Texto completo disponível

Citações Citado por
16
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests

Jean, Shio-Shin ; Hsieh, Tai-Chin ; Hsu, Chin-Wan ; Lee, Wen-Sen ; Bai, Kuan-Jen ; Lam, Carlos

Journal of microbiology, immunology and infection, 2016-12, Vol.49 (6), p.924-933 [Periódico revisado por pares]

England: Elsevier B.V

Texto completo disponível

Citações Citado por
17
Case Commentary: Imipenem/Cilastatin and Fosfomycin for Refractory Methicillin-Resistant Staphylococcus aureus Infection: a Novel Combination Therapy
Case Commentary: Imipenem/Cilastatin and Fosfomycin for Refractory Methicillin-Resistant Staphylococcus aureus Infection: a Novel Combination Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Case Commentary: Imipenem/Cilastatin and Fosfomycin for Refractory Methicillin-Resistant Staphylococcus aureus Infection: a Novel Combination Therapy

Sakoulas, George

Antimicrobial agents and chemotherapy, 2020-12, Vol.65 (1) [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

Citações Citado por
18
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin

Bhagunde, Pratik ; Colon‐Gonzalez, Francheska ; Liu, Yang ; Wu, Jin ; Xu, Shiyao Sherrie ; Garrett, Graigory ; Jumes, Patricia ; Lasseter, Kenneth ; Marbury, Thomas ; Rizk, Matthew L. ; Lala, Mallika ; Rhee, Elizabeth G. ; Butterton, Joan R. ; Boundy, Keith

British journal of clinical pharmacology, 2020-05, Vol.86 (5), p.944-957 [Periódico revisado por pares]

England: John Wiley and Sons Inc

Texto completo disponível

Citações Citado por
19
Imipenem/Cilastatin/Relebactam for Complicated Infections: A Real-World Evidence
Imipenem/Cilastatin/Relebactam for Complicated Infections: A Real-World Evidence
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem/Cilastatin/Relebactam for Complicated Infections: A Real-World Evidence

Sansone, Pasquale ; Giaccari, Luca Gregorio ; Di Flumeri, Giusy ; Pace, Maria Caterina ; Pota, Vincenzo ; Coppolino, Francesco ; Brunetti, Simona ; Aurilio, Caterina

Life (Basel, Switzerland), 2024-05, Vol.14 (5), p.614 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
20
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial

Kim, Jong Wook ; Chung, Joowon ; Choi, Sang-Ho ; Jang, Hang Jea ; Hong, Sang-Bum ; Lim, Chae-Man ; Koh, Younsuck

Critical care (London, England), 2012-02, Vol.16 (1), p.R28-R28 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (2.356)
  2. Revistas revisadas por pares (2.013)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (2.180)
  2. Book Chapters  (102)
  3. Newsletter Articles  (47)
  4. Verbetes  (11)
  5. magazinearticle  (10)
  6. Reports  (5)
  7. Resenhas  (2)
  8. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1988  (38)
  2. 1988Até1996  (116)
  3. 1997Até2005  (375)
  4. 2006Até2015  (806)
  5. Após 2015  (1.079)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (2.262)
  2. Japonês  (246)
  3. Alemão  (33)
  4. Português  (13)
  5. Francês  (9)
  6. Turco  (3)
  7. Italiano  (1)
  8. Norueguês  (1)
  9. Coreano  (1)
  10. Chinês  (1)
  11. Espanhol  (1)
  12. Indeterminado  (1)
  13. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Manganote, E
  2. Staut, L
  3. Henry, M
  4. Rizzi, C
  5. Viterbo, F

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Antibiotics
  5. Infectious Diseases

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.